Evidence map›Paper›PMID 36566191›Full record

Observational studyBMC pediatrics2022

New insights on Noonan syndrome's clinical phenotype: a single center retrospective study.

Francesco Baldo, Alice Fachin, Beatrice Da Re, Elisa Rubinato, Marco Bobbo, Egidio Barbi

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinical and Genetic Characterization of Noonan Syndrome in a Colombian Pediatric CohortJournal of clinical research in pediatric endocrinology · 2026
    Observational
  4. Largely preserved vestibular function despite severe-to-profound hearing loss in Noonan syndrome spectrum disorders.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Noonan Syndrome, Cancer Risk, and Growth Hormone TreatmentJournal of clinical research in pediatric endocrinology · 2025
    Review
  10. Review
  11. Article
  12. Noonan syndrome withTranslational pediatrics · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Francesco BaldoDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Alice FachinDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy. fachin.alice94@gmail.com.
Beatrice Da ReDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Elisa RubinatoInstitute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Marco BobboInstitute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Egidio BarbiDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
University of Trieste · ITIRCCS Materno Infantile Burlo Garofolo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNoonan syndrome (NS) is a clinically and genetically heterogeneous disorder. Since its clinical phenotype is often mild and difficult to differentiate from other syndromes, its diagnosis can be challenging and its prevalence in the pediatric population is most certainly underestimated. The difficulty in identifying Noonan syndrome is also increased by the fact that genetic tests are currently not able to detect an underlying mutation in around 10% of the cases.

methodsThis is a retrospective, observational study conducted at the Institute for Maternal and Child "Burlo Garofolo" in Trieste, Italy. We recruited all the patients with clinical and/or genetic diagnosis of NS who were evaluated at the Department of Pediatrics between October 2015 and October 2020. Statistical analyses were performed with IBM SPSS Statistics software. The association between discrete variables has been evaluated through chi-squared test, indicating statistically significant p with Pearson test or Fischer test for variables less than 5.

resultsWe recruited a total of 35 patients affected by Noonan syndrome. In 24 patients (75%) we identified an underlying genetic substrate: 17 patients had a mutation on PTPN11 (61%), 2 in SOS1, KRAS and SHOC2 (7% each) and only 1 in RAF1 (4%). 25% of the subjects did not receive a genetic confirm. As for the phenotype of the syndrome, our study identified the presence of some clinical features which were previously unrelated or poorly related to NS. For example, renal and central nervous system abnormalities were found at a higher rate compared to the current literature. On the contrary, some features that are considered very suggestive of NS (such as lymphatic abnormalities and the classical facial features) were not frequently found in our population.

conclusionsIn our analysis, we focused on the main phenotypic features of NS, identifying various clinical manifestation that were not associated with this genetic condition before. This could be helpful in raising the knowledge of NS's clinical spectrum, facilitating its diagnosis.

Indexed as

Noonan SyndromeChildGenetic TestingHumansIntracellular Signaling Peptides and ProteinsMutationPhenotypeProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins c-rafProto-Oncogene Proteins p21(ras)Retrospective StudiesSOS1 ProteinIntracellular Signaling Peptides and ProteinsKRAS protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins c-rafProto-Oncogene Proteins p21(ras)PTPN11 protein, humanRaf1 protein, humanSHOC2 protein, humanSOS1 ProteinSOS1 protein, humanDiagnosisGenetic diagnosisNoonan syndromePhenotypeRASopathies

Identifiers

PMID36566191
PMCPMC9789552
OpenAlexW4313278756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.